The ASCO Post Media Kit | 2022

About The ASCO® Post

The ASCO Post products group

Mission

The ASCO® Post, in partnership with the American Society of Clinical Oncology (ASCO), provides ASCO members, and all with an interest in oncology, access to important clinical news, summaries of timely peer-reviewed literature, and authoritative viewpoints on a variety of issues in oncology. Available in print and digitally, The ASCO® Post works to keep readers informed about the latest clinical oncology data. Under the guidance of James O. Armitage, MD, Editor-in-Chief, and past ASCO President, and a team of more than 40 editorial advisors from the United States and abroad, each issue features highly validated coverage of clinical cancer research and practice issues complemented by thoughtful commentary from leaders in the field of clinical oncology.

Keeping oncology clinicians up-to-date on:

The changing health-care environment

The ASCO® Post covers important policy issues related to value in cancer care, cost of cancer drugs, and funding for cancer research, all essential to advances in cancer care.

What your peers are reading

The ASCO® Post is the number one read oncology newspaper. Surveys indicate oncologists turn to The ASCO® Post to stay on top of important literature, data, and happenings in clinical oncology.

The newest drugs

The ASCO® Post announces FDA approvals of novel drugs or new indications for existing oncology drug products in every issue, keeping readers up-to-date on the latest treatments.

Timely oncology news

The ASCO® Post reports on clinical data presented at oncology meetings worldwide.

What's new with ASCO®

In every issue, The ASCO® Post publishes "Direct From ASCO," featuring editorial content provided by ASCO and written for ASCO members. Readers learn about ASCO initiatives and opportunities, including ASCO Leadership Development opportunities, Conquer Cancer (the ASCO Foundation) the Quality Oncology Practice Initiative (QOPI) certification program, Cancer.Net, and much more.

The most important trends in oncology

The ASCO® Post educates readers about important trends in cancer care, including the role of immunotherapy in patient care, plus reports on targeted therapies, checkpoint inhibitors, vaccines, and more.

The latest guidelines

The ASCO® Post regularly publishes comprehensive coverage of new and updated clinical guidelines from ASCO and the National Comprehensive Cancer Network (NCCN).


About ASCO

In 1964, a group of seven cancer physicians banded together with a single purpose—to improve the care of people with cancer. At the time, cancer was viewed as a monolithic and frequently incurable disease, with only a handful of hard-to-tolerate and mostly ineffective therapies available. Stigma and silence left many patients with cancer with little support or information.

ASCO has held true to this vision. Over five decades, ASCO and its members have established and advanced the field of modern clinical oncology. In many ways, the story of ASCO is the story of progress against cancer. As ASCO grew from its original seven members to nearly 45,000 oncology professionals, national funding for cancer research increased from less than $200 million to more than $5 billion annually. The number of drugs available to treat cancer grew from just a handful to more than 170. And, most importantly, patients are living longer and better lives. ASCO’s members, together with patients with cancer, patient advocates, and the policymakers, government agencies, and philanthropic organizations like Conquer Cancer that have invested in vital research, have enabled and delivered these remarkable advances.

Nevertheless, cancer remains one of the world’s greatest health challenges. Prevention options are few, and many cancers are still hard to diagnose and treat. But with recent breakthroughs in technology and molecular biology, cancer care is poised to change even more dramatically in the next 20 years than over the last 50. As we look to the future, ASCO is working to harness these rapid changes in science and technology to achieve even better outcomes for tomorrow’s patients.



The ASCO Post, in partnership with the American Society of Clinical Oncology (ASCO), communicates timely and unbiased news of clinical research and updates in oncology.

Since it was launched by Harborside in 2010, The ASCO® Post has delivered timely and unbiased reports on major oncology meetings across the globe, including ASCO's Annual Meeting and regional and thematic symposia. Additionally, The ASCO® Post provides readers with important summaries of evidence-based research from peer-reviewed clinical journals (fully sourced with links to original reports); notable research, data, and literature with application in the clinic, including cost considerations/implications; and columns from ASCO's membership, with perspectives on developments in oncology, quality cancer care, technology, electronic medical records, and expert opinion on the state and economics of cancer care.

The ASCO® Post publishes news from the National Institutes of Health, the National Cancer Institute, the U.S. Food and Drug Administration, the U.S. Congress, and other governmental agencies; developments in health-care reform and the impact on oncology practice; news from the pharmaceutical and manufacturing industries; issues pertinent to community practice, careers, polls, and oncology trends; and ASCO member milestones (relocations, appointments, obituaries, etc).

Each issue includes

News: Reports on clinical data presented at major oncology meetings in the United States and abroad—sidebars itemize key take-home messages, in an easy-to-read format.

Journal Spotlight: Summaries of important, timely peer-reviewed literature with expert commentary for added perspective. Plus, coverage of important papers from the ASCO publications, Journal of Clinical Oncology (JCO) and the JCO Oncology Practice (JCO OP) are highlighted in The ASCO® Post's departments, "JCO Spotlight" and "Spotlight on JCO OP."

News from the U.S. Food and Drug Administration (FDA) is included in every issue of The ASCO® Post in the departments "FDA Updates" and "In the Clinic." FDA Updates includes important news of newly approved oncology drugs and novel indications. In the Clinic examines a newly approved product in detail, explaining its indications, mechanism of action, and appropriate safety and efficacy data from pivotal trials.

Clinical Trials Resource Guide includes listings of clinical studies sponsored by the National Institutes of Health and the National Cancer Institute and/or major comprehensive cancer centers. Featured studies are those that are actively recruiting patients for participation and each entry identifies the study's purpose, primary outcome measures, principal investigators, and Clinicaltrials.gov identifier.

Society News: “Direct from ASCO” features info from ASCO briefings, Conquer Cancer awards, QOPI and CancerLinQ news, policy items, and more.

Expert Points of View in hematology-oncology with a look at the contributions these individuals have made to improve the care of patients with cancer.

Featured Op-Eds and Perspectives on important issues in hematology-oncology, including immunotherapy, precision medicine, practice guidelines, quality care, novel drugs, and more.

Expert's Corner: One-on-one interviews with Key Opinion Leaders in hematology-oncology.

Readership Rankings

ASCO Post is #1 among all oncology newpapers
in cover to cover readership*

*Among all Oncology Newspapers

#1 In Percent 4 of 4 Readers*

*Among all Oncology Newspapers


#3 In Average Page Exposures*

*Among all Oncology Publications


#3 In High Readers*

*Among all Oncology Publications


Source: Kantar Media, 2021, Tables 402 & 403 Oncology and Hematology/Oncology Office and Hospital

Circulation and ASCO Member Profile

About ASCO

History, Mission, and Vision:

  • Founded 1964
  • Approximately 45,000 members in more than 150 countries
  • Largest clinical oncology meeting in the world; ~40,000 attendees annually
  • Mission: Conquering cancer through research, education, and promotion of the highest-quality patient care
  • Vision: A world where cancer is prevented or cured, and every survivor is healthy

Frequency

Twenty-four issues including one annual special issue. Regular issues will be 2 ×/month for all months February-December with issue dates on the 10th and 25th of the month. Only one issue in January dated January 25th. The Narratives in Oncology Special Issue, dated June 3, 2022, will be mailed independently and also will be distributed at the ASCO Annual Meeting.

24 issue dates:
January 25 • February 10 • February 25 • March 10 • March 25 • April 10 • April 25 • May 10 • May 25 • June 3* • June 10 • June 25 • July 10 • July 25 • August 10 • August 25 • September 10 • September 25 • October 10 • October 25 • November 10 • November 25 • December 10 • December 25

*Special Issue: Narratives in Oncology


Effective Date and Discounts

Rates effective as of January 2022. Rate changes will be issued with 90-day written notice. Fifteen percent (15%) agency discount of gross billings on space, color, cover, and preferred position charges. Payment terms are net 30 days of invoice date. Pre-payment discounts are available; contact the publisher for more information.

Earned Rates: Earned rates are given to advertisers (parent companies and their subsidiaries) based on the total number of pages placed within a 12-month period. A spread counts as two facing pages regardless of its size (king or A-size advertisement).


Circulation — 28,165

A subscription to The ASCO Post is sent to US-based ASCO members, including oncologists, hematologists, hematologists/oncologists, surgical oncologists, gynecologic oncologists, pediatric oncologists, and radiation oncologists, as well as all other domestic nonmember medical oncologists, hematologists, and hematologists/oncologists.

Additionally, a subscription is also available as a benefit of membership to all US-based ASCO and Advanced Practitioner Society of Hematology and Oncology (APSHO) nurse practitioners, physician assistants, and oncology pharmacists.

Breakdown by Specialty

 

Medical Oncology (AMA & ASCO)

4,010

Hematology/Oncology (AMA & ASCO)

11,905

Hematologist (AMA & ASCO)

1,409

Onc & Hem/Onc (other ASCO member)

1,400

Internal Medicine (ASCO)

1,594

Nurse Practitioners & Physician Assistants
(ASCO & APSHO)

1,456

Surgical Oncologist & Surgeon (ASCO)

475

Radiation Oncologist

742

Pediatric Hem/Onc (ASCO)

582

Gynecologic Oncology (ASCO)

370

Pathologist (ASCO)

166

Oncology Pharmacist (ASCO)

467

Urologist (ASCO requesters)

128

Other ASCO Members*

3,461

Total

28,165

*Includes dermatologists, musculoskeletal oncologists, lab personnel, biostatisticians, allied health care professionals, and other field-related personnel.

U.S. Practice Location

 

Academic Medical Center/University

10,398

Training Program

4,237

Private Practice (Office or Hospital Based)

6,504

Pharmaceutical/Biotech Company

5,214

Administration

649

Government Agency

385

Staff Model HMO

250

Laboratory Research

265


ASCO Member Profile

Board Certification of US–based ASCO Members

 

Medical Oncology

9,547

Internal Medicine

9,159

Hematology

6,117

Radiation Oncology

1,141

Surgery (incl. Surgical Oncology)

783

Other

3,594

Pediatrics (incl. Pediatric Oncology)

832

Gynecologic Oncology

402

Oncology Pharmacy

286

Oncology Nursing

268

Members may choose more than one category and not all give a response—updated July 2021.

The ASCO® Post Meetings Coverage and Issue Dates

Issue Date

News Coverage (tentative)

Bonus Distribution at*

Jan 25th

American Society of Hematology (ASH),

San Antonio Breast Cancer Symposium (SABCS),

American Society for Radiation Oncology (ASTRO),

European Society for Medical Oncology (ESMO),

Palliative and Supportive Care in Cancer,

AACR-NCI-EORTC International Conference,

Society for Immunotherapy of Cancer (SITC),

ESMO Immuno-Oncology Congress,

Annual Meeting of the Society of Urologic Oncology (SUO),

European Colorectal Congress

ASCO 2022 Genitourinary Cancer Symposium

Feb 10th

ASH,

SABCS,

ASTRO,

ESMO

Association of Community Cancer Centers (ACCC)

Feb 25th

Gastrointestinal Cancers Symposium (GI Symposium),

American Association for Clinical Research Conference on Melanoma (AACR),

ASH,

SABCS

Society of Surgical Oncology (SSO),

Society of Gynecologic Oncology (SGO)

Mar 10th

GI Cancers Symposium,

Genitourinary Cancers Symposium (GU Symposium)

NCCN Annual Congress,

HOPA

Mar 25th

ASCO-SITC Clinical Immuno-Oncology Symposium,

GI Cancers Symposium,

GU Cancers Symposium

American Association for Cancer Research (AACR)

Apr 10th

Society of Surgical Oncology (SSO) Annual Meeting,

GU Cancers Symposium,

Miami Breast Cancer Conference,

Multidisciplinary Thoracic Cancers Symposium,

Society of Gynecologic Oncology Annual Meeting (SGO),

St. Gallen International Breast Cancer Conference,

NCCN Annual Conference

Oncology Nursing Society Congress

Apr 25th

AACR Annual Meeting,

NCCN Annual Conference,

St. Gallen International Breast Cancer Conference,

SGO,

Miami Breast Cancer Conference,

Annual Symposium on Pancreatic Cancer,

Association of Community Cancer Centers (ACCC)

 

May 10th

Immunotherapy of Cancer Conference,

European Lung Cancer Congress,

SSO Annual Meeting,

SGO Annual Meeting,

European Kidney Cancer Association International Meeting,

Community Oncology Alliance (COA),

ACCC

May 25th

SSO Annual Meeting,

Oncology Nursing Society Annual Congress (ONS),

SGO Annual Meeting,

ASCO 2020 Pre-Meeting Highlights,

COA,

NCCN

2022 ASCO Annual Meeting

Jun 3rd

Narratives in Oncology: Profiling oncology leaders, innovators, and pioneers

2022 ASCO Annual Meeting

Jun 10th

ASCO Annual Meeting,

AACR Annual Meeting,

NCCN Annual Conference

Jun 25th

ASCO Annual Meeting, AACR Annual Meeting

Best of ASCO Hollywood

Jul 10th

ASCO Annual Meeting,

International Conference on Malignant Lymphoma,

European Hematology Association Annual Congress (EHA)

Best of ASCO New Orleans,

IASLC World Conference on Lung Cancer

Jul 25th

ASCO Annual Meeting,

MASCC/ISOO Annual Meeting on Supportive Care in Cancer,

EHA

Best of ASCO DC,

Aug 10th

Best of ASCO, Washington, DC,

ASCO Annual Meeting,

MASCC/ISOO,

International Conference on Malignant Lymphoma,

EHA

 

Aug 25th

Best of ASCO, Hollywood,

MASCC/ISOO,

International Conference on Malignant Lymphoma,

American Head & Neck Society Annual Meeting,

Pan Pacific Lymphoma Conference,

EHA

 

Sep 10th

Best of ASCO, Washington, DC,

Best of ASCO, Hollywood,

Best of ASCO, New Orleans,

American Head & Neck Society Annual Meeting

ASCO Quality Care Symposium,

Sep 25th

Best of ASCO, New Orleans,

MASCC/ISOO,

Debates and Didactics in Hem/Onc,

IASLC (World Lung),

 

Oct 10th

IASLC,

ASTRO,

NCCN Hematologic Malignancies Congress,

JADPRO Live

Oct 25th

ASCO Quality Care Symposium,

IASLC,

Society of Hematology-Oncology (SOHO),

International Workshop on Chronic Lymphocytic Leukemia (IwCLL),

Society for Immunotherapy of Cancer (SITC)

Nov 10th

NCCN Hematologic Malignancies Congress,

ASCO Quality Care Symposium,

ESMO,

IASLC (World Lung),

IwCLL,

 

Nov 25th

NCCN Hematologic Malignancies Congress,

ESMO,

IASLC (World Lung),

ASTRO Annual Meeting,

Society of Integrative Oncology (SIO) Annual Meeting

ASH Annual Meeting,

SABCS

Dec 10th

ASTRO Annual Meeting,

ESMO,

JADPRO Live,

Chemotherapy Foundation Symposium

 

Dec 25th

ASH,

Society for NeuroOncology Annual Meeting,

Annual Meeting of the Society of Urologic Oncology (SUO),

SITC 35th Annual Conference,

SABCS

ASCO 2023 Gastrointestinal Cancers Symposium,

ASCO 2023 Genitourinary Cancers Symposium

*Subject to change. If a meeting is virtual only, no bonus distribution will be available

Disease-Specific Editorial Focus Months

Feb

World Cancer Day (February 4), National Cancer Prevention Month, Triple Negative Breast Cancer Day

Mar

Colorectal Cancer, Renal Cell Carcinoma, Multiple Myeloma

May

Melanoma

Jun

Survivorship

Jul

Sarcoma Awareness

Sep

Prostate Cancer, Gynecologic Cancers, Leukemia/Lymphoma, Childhood Cancers

Oct

Breast Cancer

Nov

Lung Cancer, Pancreatic Cancer

Print Advertising Rates

Advertising Rates – Run of Book

Black and White

Frequency

King-pg

3/4-pg

Island 1/2-Pg

1/4-page

$6,275

$5,820

$4,870

$3,395

$6,210

$5,785

$4,825

$3,375

12×

$6,160

$5,735

$4,785

$3,345

24×

$6,090

$5,695

$4,740

$3,330

36×

$6,035

$5,650

$4,690

$3,305

48×

$5,970

$5,610

$4,650

$3,290

60×

$5,930

$5,570

$4,615

$3,260

72×

$5,885

$5,520

$4,570

$3,240

96×

$5,860

$5,475

$4,520

$3,225

120×

$5,815

$5,435

$4,485

$3,195

144×

$5,780

$5,390

$4,435

$3,175

170×

$5,730

$5,350

$4,390

$3,155

194×

$5,680

$5,310

$4,350

$3,130

216×

$5,650

$5,260

$4,315

$3,115

242×

$5,600

$5,215

$4,265

$3,095

268×

$5,565

$5,185

$4,230

$3,075

304×

$5,510

$5,130

$4,180

$3,055

340×

$5,435

$5,050

$4,095

$2,995

376×

$5,380

$5,000

$4,055

$2,960

Four Color

Frequency

King-pg

3/4-pg

Island 1/2-Pg

1/4-pg

$8,800

$8,345

$7,395

$5,920

$8,735

$8,310

$7,350

$5,900

12×

$8,685

$8,260

$7,310

$5,870

24×

$8,615

$8,220

$7,265

$5,855

36×

$8,560

$8,175

$7,215

$5,830

48×

$8,495

$8,135

$7,175

$5,815

60×

$8,455

$8,095

$7,140

$5,785

72×

$8,410

$8,045

$7,095

$5,765

96×

$8,385

$8,000

$7,045

$5,750

120×

$8,340

$7,960

$7,010

$5,720

144×

$8,305

$7,915

$6,960

$5,700

170×

$8,255

$7,875

$6,915

$5,680

194×

$8,205

$7,835

$6,875

$5,655

216×

$8,175

$7,785

$6,840

$5,640

242×

$8,125

$7,740

$6,790

$5,620

268×

$8,090

$7,710

$6,755

$5,600

304×

$8,035

$7,655

$6,705

$5,580

340×

$7,960

$7,575

$6,620

$5,520

376×

$7,905

$7,525

$6,580

$5,485


Insert Rates

Island Size Insert

Frequency

2-page

4-page

6-page

8-page

$10,465

$20,330

$30,250

$40,045

$10,375

$20,150

$29,980

$39,685

12×

$10,295

$19,990

$29,740

$39,365

24×

$10,205

$19,810

$29,470

$39,005

36×

$10,105

$19,610

$29,170

$38,605

48×

$10,025

$19,450

$28,930

$38,285

60×

$9,955

$19,310

$28,720

$38,005

72×

$9,865

$19,130

$28,450

$37,645

96×

$9,765

$18,930

$28,150

$37,245

120×

$9,695

$18,790

$27,940

$36,965

144×

$9,595

$18,590

$27,640

$36,565

170×

$9,505

$18,410

$27,370

$36,205

194×

$9,425

$18,250

$27,130

$35,885

216×

$9,355

$18,110

$26,920

$35,605

242×

$9,255

$17,910

$26,620

$35,205

268×

$9,185

$17,770

$26,410

$34,925

304×

$9,085

$17,570

$26,110

$34,525

340×

$8,915

$17,230

$25,600

$33,845

376×

$8,835

$17,070

$25,360

$33,525

King Size Insert

Frequency

2-page

4-page

6-page

8-page

$13,275

$25,950

$38,680

$51,285

$13,145

$25,690

$38,290

$50,765

12×

$13,045

$25,490

$37,990

$50,365

24×

$12,905

$25,210

$37,570

$49,805

36×

$12,795

$24,990

$37,240

$49,365

48×

$12,665

$24,730

$36,850

$48,845

60×

$12,585

$24,570

$36,610

$48,525

72×

$12,495

$24,390

$36,340

$48,165

96×

$12,445

$24,290

$36,190

$47,965

120×

$12,355

$24,110

$35,920

$47,605

144×

$12,285

$23,970

$35,710

$47,325

170×

$12,185

$23,770

$35,410

$46,925

194×

$12,085

$23,570

$35,110

$46,525

216×

$12,025

$23,450

$34,930

$46,285

242×

$11,925

$23,520

$34,630

$45,885

268×

$11,855

$23,110

$34,420

$45,605

304×

$11,745

$22,890

$34,090

$45,165

340×

$11,595

$22,590

$33,640

$44,565

376×

$11,485

$22,370

$33,310

$44,125

All published rates are in USD


Premium Position Charges

Position

Charge

Fourth cover

50% over B&W rate

Third cover

15% over B&W rate

First ad

25% over B&W rate

Center spread

25% over B&W rate

Consecutive right-hand pages

20%* over B&W rate

All other guaranteed positioning

10% over B&W rate

*On 2nd and 3rd pages, up to 3 pages. For addt'l pages contact Publisher.


Color Charges

Color

Charge

Four color

$2,525

Two color standard

$845

Two color matched

$1,220

Bleed: No charge


Net Rates Cover Tips Supplied With
PI Attached and Without

Frequency

2 page supplied

2 page plus PI

$31,395

$37,395

$31,125

$37,125

12×

$30,885

$36,885

24×

$30,615

$36,615

36×

$30,315

$36,315

48×

$30,075

$36,075

60×

$29,865

$35,865

72×

$29,595

$35,595

96×

$29,295

$35,295

120×

$29,085

$35,085

144×

$28,785

$34,785

170×

$28,515

$34,515

194×

$28,275

$34,275

216×

$28,065

$34,065

242×

$27,765

$33,765

268×

$27,555

$33,555

304×

$27,255

$33,255

340×

$26,745

$32,745

376×

$26,505

$32,505


Meeting Listing Rates and Specs for Meeting Planners

Advertisements available in oncology meeting section.

Net pricing

1/4 pg 4c

$3,850

$3,655

$3,470

1/8 pg 4c

$2,785

$2,625

$2,470


Insert Conversion Program — For Multipage Insert Advertisers Only

Harborside can convert inserts of 4 pages or larger to king-sized ad pages at no cost. The converted ad will be billed at the king-sized B&W page rate times the number of pages. Digital file required. For additional information, please contact Norman W. Virtue at 631-935-7682 or nvirtue@hbside.com.


Business Reply Card (BRC) Inserts

BRCs are billed at half of a 2-page island-sized insert rate page with a minimum island half-page ad opposite. A sample of the BRC and paper must be submitted to the publisher for approval two weeks before closing date.


List Match Charge

Harborside will match any client list to The ASCO Post's circulation. The first 2 list matches are free, charge of $2,000 applies to all subsequent matches. If the client chooses to advertise to the selected audience through a demo insert, the appropriate demo charge will apply, and the initial list match fee will be waived. Maximum of 2 list matches per year per brand.


Split-Run Inserts Production Charge

Billing is based on the earned insert rate times the percentage of circulation, with a minimum of 50% of the total circulation, plus a noncommissionable production charge of $2,500. For a run-of-book split-run charge, please contact the publisher.

Note: there is a maximum of 4 split-runs per issue

Discounts and Incentives

Continuity Discounts

If multiple sized ad units are placed within the first 5 insertions, the cost of the 6th ad unit will be determined by the average dollar amount spent per issue. This amount will be credited toward the 6th insertion in a series.


ASCO Publications Combined Frequency Rate

Advertisers in ASCO Publications: The ASCO® Post, Journal of Clinical Oncology (JCO), and JCO Oncology Practice (JCO OP) combine for pages to earn the frequency rate in The ASCO® Post as well as in all the ASCO journal publications. Space purchased by a parent company and subsidiaries is combined in calculating the earned rate. When the number of insertions is greater or less than indicated by the contract, rates are adjusted accordingly. Please contact Harborside for details. Frequency will be determined by the total number of pages placed in these publications during a calendar year.

*Guaranteed frequency is based on the number of pages placed between July 2020-June 2021


Prescribing Information (PI) Discount

Advertise three or more prescribing information (PI) pages for a single ad for a brand and receive a 50% discount on the B&W page rate beginning on the third PI page. Multi-journal discount is not eligible for discounted PI pages.


Multi-Journal Discount

Each individual product advertising in ASCO’s Journal of Clinical Oncology (JCO) AND/OR ASCO’s JCO Oncology Practice (JCO OP) during the same month it advertises in The ASCO® Post will receive a $500 per page discount in The ASCO® Post. Discount is based on the matching number of pages in The ASCO® Post and JCO or JCO OP in a given month.*

*Discount is only applied to fully priced ad pages

Print Advertising Guidelines

Advertising Policies

Placement of Advertising: Interspersed within articles. Placement location is at the discretion of Harborside.


Acceptance of Advertising

All advertising is subject to approval of the Editor-in-Chief, publisher, and ASCO. New advertisements are to be received by the publisher at least two weeks before the closing date. Please email all ad proofs to Norman W. Virtue at nvirtue@hbside.com. The publisher reserves the right to label any advertisement as such for any ads that contain significant editorial content or that look like editorial pages.

The advertiser and advertising agency accept and assume liability for all content (including text, representations, illustrations, opinions, and facts) of advertisements and their compliance with all applicable laws and regulations and also assume responsibility for any claims made against the publisher or ASCO arising from or related to such advertisements.

Advertiser and advertising agency recognize and accept that the following language appears within the publication: “All statements, including product claims, are those of the person or organization making the statement or claim. Neither the publisher nor ASCO adopts any such statement or claim as its own, and any such statement or claim does not necessarily reflect the opinion of the publisher or ASCO.”

In the event that legal action or a claim is made against the publisher or ASCO arising from or related to such advertisements, the advertiser and advertising agency agree to fully defend, indemnify, and hold harmless the publisher and ASCO and to pay any judgment, expenses, and legal fees incurred by the publisher or ASCO as a result of said legal action or claim.

In addition, the publisher reserves the right to reject or discontinue any advertising for any reason. This right shall not be deemed to have been waived by acceptance or actual use of any advertising matter.

The publisher reserves the right to label any advertisement as such for any ads that contain significant editorial content or that look like text pages. The publisher is not liable for delays in delivery and/or nondelivery due to any condition beyond the control of the publisher affecting production or delivery in any manner.

The publisher reserves the right to reject any advertising that it believes is not in keeping with the publication’s standards.

Advertiser and advertising agency agree to indemnify, defend, and hold harmless the publisher from any and all liability for content (including text, illustrations, representatives, sketches, maps, trademarks, labels, or other copyrighted matter) of advertisement printed or the unauthorized use of any person’s name or photography arising from the publisher’s reproduction and publishing of such advertisements pursuant to the advertiser’s or agency’s order.


Earned Frequency

Earned Frequency: Harborside will determine the number of pages and fractions of pages placed in The ASCO Post during the year.

Combined Frequency: Harborside will combine all advertising insertions of a parent company and its subsidiaries to determine the earned rate.


Services

A) Reprint/ePrint Orders

Commercial article reprints and electronic reprints (ePrints) are available.

Please contact Amy Schriver, Manager, Content Solutions, The Sheridan Press.

800-635-7181 Ext. 8184; Amy.schriver@sheridan.com

B) Availability of ASCO Mailing List

Contact Infocus Marketing Inc. List Manager, 4245 Sigler Road, Warrenton, VA 20187; 540-428-3251; or www.infocusmarketing.com

C) Sponsorship Opportunities Available

Supplements, special issues, newsletters, patient education material, and additional customized opportunities available.


Agency Discounts

Fifteen percent (15%) of gross billings on space, color, cover, and preferred position charges. Additional production charges are noncommissionable.

Print Specifications & Closing Dates

File Submissions

SWOP standards apply. Submit only high-resolution CMYK PDF formatted files. Convert all spot colors to CMYK. All fonts and images must be embedded. Files should indicate trim and bleed.

Contact the Production Manager at nvirtue@hbside.com for additional specifications and production questions.


Advertising Sizes


Requirements for Cover Tips, Inserts or Outserts

2 mockups must be provided for proposed piece. Mockups are needed to head off potential problems during binding and allow Publisher to provide feedback on how to correct any problems prior to delivery. Once samples are received, it will also be determined if additional postage and binding charges will be necessary. For a simple two-sided piece, a mockup is not necessary. All other configurations require mockups, which are due 6 weeks before due date to printer.

Send samples to:

Norman Virtue, Harborside, 244 Hillside Ave, Valley Stream, NY, 11580

Send PDF file of the creative for preapproval by ASCO to: nvirtue@hbside.com

Once Approved

Ship printed pieces to:

Royle Printing
Jenny Turk - CSR
745 S Bird Street, Sun Prairie, WI 53590

All inserts must be palletized

  1. A packing list must be included with all shipments
    1. The list should include: Royle’s Job #, project name, issue date, weight, total quantity, quantity per box, & total skid number
  2. Pallet identification on at least 2 sides includes:
    1. Royle’s Job #
    2. Project name
    3. Issue Date
    4. Royle Customer Service Rep’s name
    5. Net weight
    6. Quantity
    7. Number of cartons
    8. Skid Number
    9. Supplier’s name
    10. Affix a sample to each side of skid
  3. Bulk Packing in skid container
    1. All inserts must be brick stacked no higher than in 6” lifts with all lifts facing same direction
    2. Lifts must be separated by chipboard for additional protection
    3. Multiple versions must be in separate containers
    4. No Shrink-wrapped bundles
  4. Carton Packing
    1. Carton packing should be used when the nature of product will not allow for brick stacking or additional protection of the product is required
    2. Multiple versions may be placed on the same pallet if cartons are clearly marked and identified, 1 of ____, with a sample attached to each carton
    3. No Shrink-wrapped bundles
    4. Compensate product only once per carton
  5. Pallets
    1. 40" × 48" and not to be packed higher than 48"
    2. Must be waterproof wrapped and securely banded
    3. Cannot exceed 2,000 lbs/gross
  6. Deadlines
    1. All furnished inserts are due to Royle at the time art files are due for the main job or when CSR communicates an exact date
    2. Inserts arriving 30 days prior to the binding date will be placed in inventory with a storage fee billed to Royle’s customer
    3. Any inserts arriving less than 5 days prior to binding date must be cleared thru the Royle CSR
  7. Receiving
    1. The plant will receive materials Monday thru Friday (7 AM to 5 PM)

For additional information, contact Royle Printing: (608) 837-5161 ext. 433 or email: receiving@royle.com

Cover Tip Specifications:

  • Quantity: 32,700
  • Standard 2 page (front and back)
  • Maximum trim size: 10.25" wide × 6" high
  • Minimum trim size: 6" wide × 4" high
  • Minimum paper weight: 70# Text
  • Cover tip should be supplied trimmed. Tip will be flush (with variation of up to 0.125") to spine and foot of cover.
  • Two samples are required for preapproval and evaluation, along with a PDF of the file for ASCO approval.
  • Two plain paper mock-ups are required for preapproval and evaluation.
  • A PDF of the file is required for ASCO approval.

The ASCO Post accepts cover tip variations–cover tip with PI affixed to back, pocket cover tips with PI enclosed, etc. It is recommended that there be 2" clearance between the edge of the PI and the gutter edge of the cover tip.

Insert Specifications:

  • Quantity: 32,700
  • Paper weight: 60 – 80# text maximum
  • Standard Dimensions:
    Bleed: 8.375" × 11.125"
    Trim: 8.125" × 10.875"
    Live: 7.5" × 10"
  • King Dimensions:
    Supplied size: 10.5" x 14"
    Insert will be trim at the top and bottom to a final size of 10.5" x 13.75"
    Live: 9.25" x 12.75" (0.75" from face trim)
  • Inserts should be supplied folded.
  • Inserts are tipped in to the publication flush to the gutter and foot.
  • Saddle-stitched inserts are available at an extra cost. Such inserts require a 4.5" hanger.
  • Two plain paper mock-ups are required for preapproval and evaluation.
  • A PDF of the file is required for ASCO approval.

Outsert Specifications:

  • Quantity: 32,700
  • Outserts must be supplied as single units. They cannot be supplied individually shrink wrapped. Any PI information must be spot glued inside the Outsert.
  • Dimensions: Outserts are limited to the size of the host publication 10.5" × 13.75".
  • Two plain paper mock-ups are required for preapproval and evaluation.
  • A PDF of the file is required for ASCO approval.

Material Storage

Files are held for one year and then destroyed, unless instructed otherwise in writing. Unused inserts will be destroyed one month after issue mails.


Insertion Order Submissions

Email: hspadorders@hbside.com
Insertion order should include an ad code or unique identifier to help properly identify the corresponding ad material.

Ad Materials to:

email: hspadmats@hbside.com
FTP: prodweb2.hbrsd.com
Username: hspsales
password: Connect#9

We recommend using a secure file transfer protocol. Such as SFTP FileZilla

Color Proofs to:

Norman W. Virtue, The ASCO Post,
244 Hillside Ave
Valley Stream, NY 11580
Tel: 631-935-7682, Fax: 631-692-0805

Send sample to:

Norman Virtue
244 Hillside Ave
Valley Stream, NY 11580


Closing Dates

Issue Date

Insertion Order Due

Ad Material Due

Inserts Due

Jan 25th

12/23/21

1/5/22

1/10/22

Feb 10th

1/7/22

1/14/22

1/21/22

Feb 25th

1/24/22

1/31/22

2/7/22

Mar 10th

2/7/22

2/14/22

2/21/22

Mar 25th

2/24/22

3/3/22

3/10/22

Apr 10th

3/9/22

3/16/22

3/23/22

Apr 25th

3/24/22

3/31/22

4/7/22

May 10th

4/11/22

4/18/22

4/25/22

May 25th

4/20/22

4/27/22

5/4/22

Jun 3rd

4/22/22

4/29/22

5/6/22

Jun 10th

5/9/22

5/16/22

5/23/22

Jun 25th

5/23/22

5/27/22

6/6/22

Jul 10th

6/10/22

6/17/22

6/24/22

Jul 25th

6/24/22

7/1/22

7/8/22

Aug 10th

7/8/22

7/15/22

7/22/22

Aug 25th

7/25/22

8/1/22

8/8/22

Sep 10th

8/10/22

8/17/22

8/24/22

Sep 25th

8/25/22

9/1/22

9/8/22

Oct 10th

9/9/22

9/16/22

9/23/22

Oct 25th

9/23/22

9/30/22

10/7/22

Nov 10th

10/10/22

10/17/22

10/24/22

Nov 25th

10/24/22

10/31/22

11/7/22

Dec 10th

11/10/22

11/17/22

11/23/22

Dec 25th

11/23/22

11/30/22

12/7/22

Website Advertising Opportunities

ASCOPost.com

  • ASCOPost.com is the home of breaking oncology news, including current and past issues of The ASCO Post
  • The “Today in Oncology” section, located on the home page of ASCOPost.com, is a newsfeed updated daily with original news reports of meeting abstracts and recently published peer-reviewed literature
  • The ASCO Post Newsreels is a video program including coverage from major oncology meetings and interviews with thought-leaders throughout the field
  • ASCOPost.com is fully searchable by topic or keyword

Ad Sizes Available

  • Leaderboard: 728 × 90*
  • Medium Rectangle: 300 × 250
  • Mobile Leaderboard: 320 × 50

*On mobile size displays the 728 × 90 ad location is replaced with a 320 × 50 banner ad.

Feedback

ASCOPost.com 2021 U.S. Average Stats*

 

Sessions Per Month

143,300

Users Per Month

101,000

Pageviews Per Month

179,950

Time on Site

0:16:20

Impressions Per Month

552,795

*Based on US average stats Jan 2021-June 2021 Google Analytics, Google Ad Manger

ASCOPost.com 2021 Average Stats*

EX-US

Sessions per Month

106,229

Users per Month

72,400

Time on Site

0:03:51

Pageviews Per Month

136,000

Impressions Per Month

417,000

*Based on Ex-US average stats Jan 2021-June 2021 Google Analytics, Google Ad Manger
For custom quotes by country, contact your representative.

For rates and availability please contact your representative for details.

Available with ASCO Publications Network

ASCO Publication Network

All ASCO publication website impressions are now exclusively available through multi channel high SOV tumor specific segments.

Each segment includes ASCO publication e-newsletters, ROS website banners, and targeted banners to self identified ASCO members and/or high readers of specific content and contextual impressions.

Business Intelligence Report

Including

  • Profession Breakouts
  • Target List Engagement
  • Self Identified Specialist Analysis
  • Traffic Source Path
  • And more...

Business Intelligence Report available for qualifying advertisers


Reaching this audience has never been more efficient!

  • Ads served to self identified ASCO members and/or high engagers of specific content.
  • Broad reach via ROS advertising
  • E-mail based advertising
  • Contextual targeted banners to disease specific content
Reaching The Audience

New! Hyper-targeted segments now available

  • Breast
  • Colorectal
  • Gastrointestinal
  • Genitourinary
  • Gyn Onc
  • Head & Neck
  • Hematology
  • Immunotherapy
  • Informatics
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Practice Management
  • Precision Oncology
  • Rare Diseases
  • Renal Cell
  • Supportive Oncology
  • And more...

Email Advertising Opportunities

E-TOC – The ASCO Post

  • Articles from each issue will be highlighted in the Electronic Table of Contents (E-TOC)
  • Short summary with a direct link to the article on ASCOPost.com
    as well as to homepage included
  • Delivers approximately one week before issue is received via mail

Circulation*

USA

EX-US

Total Distribution (Average)

19,500

9,000

ASCO Members

15,000

8,300

Requesters

3,300**

1,800

*Based on average. Subject to change.

**includes 1,500 APHSO members

Ads Available

  • Leaderboard Banner: 728 × 90
  • Medium Rectangle: 300 × 250

View Ad Sizes and Placement

Schedule-24 ×/year

Issue Date

Email Date

Ad Due Date

Commitment Date

01/25/22

01/25/22

01/18/22

01/11/22

02/10/22

02/10/22

02/03/22

01/27/22

02/25/22

02/25/22

02/18/22

02/11/22

03/10/22

03/10/22

03/03/22

02/24/22

03/25/22

03/25/22

03/18/22

03/11/22

04/10/22

04/11/22

04/04/22

03/28/22

04/25/22

04/25/22

04/18/22

04/11/22

05/10/22

05/10/22

05/03/22

04/26/22

05/25/22

05/25/22

05/18/22

05/11/22

06/10/22

06/10/22

06/03/22

05/27/22

06/25/22

06/24/22

06/17/22

06/10/22

07/10/22

07/11/22

07/04/22

06/27/22

07/25/22

07/25/22

07/18/22

07/11/22

08/10/22

08/10/22

08/03/22

07/27/22

08/25/22

08/25/22

08/18/22

08/11/22

09/10/22

09/09/22

09/02/22

08/26/22

09/25/22

09/26/22

09/19/22

09/12/22

10/10/22

10/10/22

10/03/22

09/26/22

10/25/22

10/25/22

10/18/22

10/11/22

11/10/22

11/10/22

11/03/22

10/27/22

11/25/22

11/23/22

11/16/22

11/09/22

12/10/22

12/09/22

12/02/22

11/25/22

12/25/21

12/22/22

12/15/22

12/08/22

2021 Average Stats*

USA

EX-US

Open Rate

36.88%

37.00%

Opens

7,300

4,780

Email Click Through Rate

17.97%

22.24%

*Based on Average Stats Jan-Sep 2021

Send all digital material to digitalads@hbside.com


The ASCO Post Evening News

  • The ASCO Post Evening News, developed by Harborside in collaboration with ASCO, is an original newsletter distributed via email on weekday evenings to more than 30,000 oncology professionals, including all ASCO members
  • Features original reporting of news from professional meetings, conferences, educational programs, and peer-reviewed scientific journals
  • Summaries of recent oncology news featured on The ASCO Post website and highlights from the Newsreels video series
  • Episodes of the ASCO Post Podcast, audio summaries of breaking oncology news, are featured in most editions of the Evening News

Trending In

  • Trending In is a personalized monthly e-Newsletter, deployed to specialists and high engagers within specific topic areas
  • Topic Areas Include: Breast, Colorectal, GI, GU, Hematology, Leukemia, Lung, Lymphoma, Multiple Myeloma & Skin Cancer
  • Monthly deployments include four banner positions, with each send sold at a 50% SOxV (2 banners per advertiser)

Available Topics

List Sizes

Breast Cancer

6,500

Colorectal Cancer

1,300

Gastrointestinal Cancer

4,500

Genitourinary Cancer

3,000

Hematology

7,500

Leukemia

2,500

Lung Cancer

4,700

Lymphoma

2,500

Multiple Myeloma

1,500

Skin Cancer

1,700

For rates and availability, please contact your representative for details.

Email Distribution*

USA

EX-US

Total Distribution (Average)

19,500

9,000

ASCO Members

14,500

7,800

Requesters

3,000

2,500

Advance Practitioners in Oncology (APSHO)

1,500

N/A

*Based on average. Subject to change.

Issued: Daily (On weekdays, as well as some weekend meeting dates)

Benefits

  • Consistency of ad message and increased frequency
  • Ability for clicks/links
  • Maximum of six ads per issue so high SOV - Minimum 16% of SOV

2021 Average Stats*

USA

EX-US

Open Rate

36.84%

47.05%

Opens

7,600

4,900

E-mail Click-Through Rate

14%

18.5%

*Based on Average Stats Jan-Oct 2021

ASCO Members Read and Review The ASCO® Post Evening News:

  • Read at least 1×/week: 95%
  • Read 3×/week or more: 70%
  • Read daily: 33%
  • 70% ranked The ASCO® Post Evening News as useful or very useful to their practice

In an independently audited and tabulated email survey of all ASCO members conducted in August 2015 and based on 421 US respondents

Major oncology meeting dates available at a premium

Send all digital material to digitalads@hbside.com

 

The ASCO® Post Meeting Highlights & Almanacs

The ASCO Post Meeting Highlights

Meeting Highlights are special A-sized (not tabloid) editions of The ASCO Post, featuring:

  • Clinical highlights of major oncology meetings
  • News coverage of plenary presentations and late-breaking abstracts
  • Introduction by Guest Editor providing expert clinical perspectives on the key takeaways from the meeting
  • 10,000 Added value ROS Impressions on ASCOPost.com
  Print Digital
Conference Specialty Audience Sent With Issue Print Circulation Production Deadline E-TOC #1* E-TOC #2**
American Society of Hematology** Hematology February 25th 14,000 1/8/21 19,500 8,000
San Antonio Breast Cancer Symposium Breast Cancer March 10th 6,993 1/22/21 19,500 7,400
IASLC World Conference on Lung Cancer Lung September 25th 5,979 8/24/21 19,500 5,800
ESMO Med Oncs and Hem Oncs October 25th 14,000 9/24/21 19,500 8,600

Note: Bonus distribution (approx 100 copies) may be available at other meetings of interest.

Other meetings available include SOHO, SGO, ASTRO and others.

*sent to The ASCO Post E-TOC circulation

**As part of the ASH Annual Packages

Pricing for The ASCO Post Meeting Highlights

Package

Price

eTOCs

Website

Cost

SOV #1

Cover Tip + TOC

50% SOV on Email #1 + Email #2

50% SOV of impressions

$60,000 net

SOV #2

Cover 2 + Cover 4

50% SOV on Email #1 + Email #2

50% SOV of impressions

$60,000 net

See ad specs in the Almanacs section below


The ASCO Post Almanacs

A round-up of news items specific to a disease site and/or tumor type, including important clinical trial data, emerging therapies, and expert perspectives. The ASCO Post Almanacs are distributed via mail and emailed to a self-identified target audience plus Med Onc and/or Hem Onc readers of The ASCO Post

Advertising Package

50% SOV includes print and digital components.

Specifications for Meeting Highlights Issues and Almanacs

A-size
Bleed: 8.375" × 11.125"
Trim: 8.125" × 10.875"
Safety: 7.625" × 10.375"

A-size spread
Bleed: 16.5" × 11.125"
Trim: 16.25" × 10.875"
Safety: 15.75" × 10.375"
with a 0.5" safety down the middle

The Almanacs are special A-sized (not tabloid) editions of The ASCO Post, featuring:

  • Review of the year's news in a specific area of cancer, with a look at what's on the horizon
  • Introduction by Guest Editor offering expert perspective on the major clinical advances over the past year and highlighting their relevance to practicing oncologists.

Topic areas available* include:

April

Head and Neck Cancers

May

GU Cancers, Melanoma

June

Supportive Care

July

Lung Cancers

August

Sarcoma

September

CNS Malignancies, GI Cancers, GYN Cancers, Prostate Cancers

October

Breast Cancer

November

Hematologic Malignancies

*Issue dates are flexible, please contact your representative for more information.

Pricing for Almanacs

Package

Price

eTOCs

Website

Cost

SOV #1

Cover Tip + TOC

50% SOV on Email #1 + Email #2

50% SOV of impressions

$60,000 net

SOV #2

Cover 2 + Cover 4

50% SOV on Email #1 + Email #2

50% SOV of impressions

$60,000 net

For more information, contact your sales representative or email us at apninfo@hbside.com

Additional Advertising Opportunities

The ASCO Post Video Roundtable Program

  • Video roundtable of 2–3 KOLs and 1 chair/moderator, consisting of a 3–4 part series. Each part is 7–15 minutes in length.
  • Content is based on a therapeutic area of focus discussing one or more patient cases.

Includes:

  • Banner ads surrounding Roundtable video series
  • Banner ads within Harborside launch e-blast
  • Advertiser promotional video asset housing within roundtable library on ascopost.com AND OncologyGo (can be branded or unbranded)

Timing: Up to 12 month opportunity

SOV Per Roundtable: 50%-100%

Guarantees: Page Visits

Rate type: CPE

Topic areas available* include:

Date

Topic

February

Hematology

April

Lung

June

Genitourinary

August

Immunotherapy

October

Gastrointestinal

December

Breast

*Issue dates are flexible, please contact your representative for more information.


Journal Marks

Journal Marks offer advertisers excellent visibility by providing The ASCO Post readers a removable tab that carries your message.

Rate: $25,950

Rate includes printing, and is for a 2 pg ad plus the removable tab. For larger ad units, please contact Harborside for a custom quote.

Artwork, design, and content must be approved prior to printing.

Contact

Norman W. Virtue (nvirtue@hbside.com)


Podcasts

  • A podcast with highlights from the week's news.
  • Opportunity is 100% SOV support on Podcast landing page
  • 15 second pre-roll unbranded bumper advetisement.
  • For example, this podcast in brought to you in part by XXXX company. Learn more about xxxx company-Oncology products by visiting xxxxx.com”
  • 1 podcast per week
  • $5,000 net per month (includes all podcasts produced within the month)
  • 5% discount for 6 month commitment
  • Average Monthly Downloads: 3,968
  • 3 Month Minimum commitment

Sponsored Video/Newsreels Asset Housing

  • Native tile within Newsreels section
  • The ASCO® Post video viewership is high and engaging. Depending on content, the views vary from approximately 100 to 1,000 views, however, some can reach up to several thousand.
  • Percentage watched per video is approx 70%. 
  • Minimum of 3 months per campaign.
  • 2 slots available per month
  • Up to 3 native tiles rotated per 3 month period

ASCO Annual Meeting Program

May-July

Print

  • Best of JCO Annual Meeting Edition
  • Premium positions per issue: Cover-Tip, Cover 4, Cover 2, and TOC positions

Digital

  • 15 unique ASCO-related emails
  • 75,000 run-of-site and conference-targeted advertising

*Digital-only option available upon request

25% SOV


ASH Annual Meeting

Oct-Dec OR Dec-Feb

Print

  • The ASCO Post ASH Annual Meeting Highlights
  • Best of JCO ASH Meeting Edition
  • Premium positions per issue: Cover-tip, Cover 4, Cover 2 and TOC positions

Digital

  • 15 unique ASH-related emails
  • 75,000 Run-of-Site & Conference Targeted Advertising

*Digital-only option available upon request

25% SOV

Sponsored Content Opportunities

Program Details

Content Strategy

  • Collaboration with Harborside Studio to determine topics and approach

Content Creation

  • 2,000-word article created and edited by Harborside Studio

Interactive Graphics

  • 2 custom figures or tables created and edited by Harborside Studio
  • Slide-in quotes and imagery

Awareness

  • 6-month program includes drivers on ASCOPost.com and JCO.org homepages
  • The ASCO Post Evening News eNewsletters
  • Harborside Review eBlasts

Guarantee

  • 1,000 visits

Digital Specifications

Specification

Website

e-TOC/The Asco Post Evening News

Accepted ad sizes

Leaderboard (728 × 90)

Medium Rectangle (300 × 250)

Mobile (320/300 x 50)

Leaderboard (728 × 90)

Medium Rectangle (300 × 250)

Ad expansion sizes

Leaderboard (728 × 315) (Expands down)

Medium Rectangle (600 × 250) (Expands left)

N/A

Ad expansion notes

Ad must require user click initiation for expansion. Expanded ad must include
clearly visible close controls. Rollover to
expand ads are not accepted.

N/A

Ad formats

JPG, GIF, HTML5, Javascript,
third-party served ads

JPG, GIF, animated GIF

Maximum initial file size

160K

60K

Rich media file size

200K

N/A

Animation time

15 seconds, 3 frames, 3 loops

15 seconds, 3 frames, 3 loops**

Frames per second (FPS)

24 FPS

24 FPS

Border

All ads with white or partially white
background must use a 1-pixel
dark color border

All ads with white or partially white background must use a 1-pixel dark color border

Maximum Ad Resource Requests ***

15

N/A

All ad creative is due one week prior to live date and is subject to approval by ASCO. Email creative must be finalized no later than 72 hours prior to deployment. HTML5 ads must be provided as soon as possible for testing purposes.

All ad creative is subject to approval from the American Society of Clinical Oncology. For times when the user’s browser does not support creative functionality (i.e. Flash™, HTML5), provide a standard image file.

**Animated .gif files should resolve into a comprehensive static image.

***Resource request limits include any tracking scripts that the agency/advertiser may be utilizing in conjunction with their campaign.

‡ Please provide alternative text (up to 64 characters including spaces).

Interactive ads will allow for unlimited file load after user-initiated interaction. User initiation is the willful act of a user to engage with an ad. Users may interact by clicking on the ad.

File weight calculation: All files for the ad, including supporting files and agency supplied tracking scripts, must be included as part of the maximum file weight calculation for all file limits load.

For E-TOC Images, please provide alternative text (up to 64 characters
including spaces).

Keyword Blocking: If a keyword blocker is being utilized, all keywords need to be included within the IO in advance of acceptance. Failure to do so, will result in advertiser being billed for blocked impressions.

HTML5 Best Practice Notes:

HTML5 ads are like mini web pages. You can improve initial display by following a few guidelines:

  • Provide inline css and use HTML to deliver initial display resources as much as possible.
  • Limit initial dependencies on any render-blocking .js or .css
  • Load interactive elements as a deferred or secondary subload, but keep them efficient using techniques such as caching.
  • Defer heavy file weights until user initiates interaction.
  • Use techniques such as byte-serving to download partial content and to optimize for auto-play video.
  • Avoid any unnecessary downloads.
  • Combine all supporting files (e.g. JavaScript toolkits, libraries, HTML, and CSS) whenever possible.

Ads must not load more than 15 supporting files, including any agency supplied tracking scripts.

Use well-distributed, cached libraries to provide supporting files instead of providing them with the ad.

Check device and bandwidth and tailor supporting files and other elements to the environment and experience.

Harborside utilizes a number of viewability/ivt analyzation tools for comprehensive data on advertising CAMPAIGNS. If there is a 10% difference between third-party reporting, a conversation ensues between client and Harborside.

† No Advertising shall include any pixels, tags, Flash containers, or any other type of information collection software code (i.e. any such pixel, tag, code or device commonly referred to as a “Pixel”), nor place any beacons, cookies, or other information collection devices on the browsers of users unless expressly approved in writing by Harborside. If Harborside approves the inclusion of a Pixel in an advertisement, then unless and only to the extent that such approval contains an express exception, (i) Advertiser may not use such Pixel to collect any personally-identifiable information (PII) with respect to any The ASCO Post user, (ii) no such Pixel can be flash or object based, (iii) No cookies may be placed on a user’s system, (iv) Advertiser will not link any non-PII that it collects to any PII that it may have from any other source and (v) Advertiser will not update any existing profile or create any profile in its database based on any data collected on the The ASCO Post site, including the fact that someone is a The ASCO Post user or any information derived from the information in the referring URL.

We cannot honor viewability related campaign goals if ads are supplied that do not meet the specifications supplied in the grid above.

IVT-related campaign requirements cannot be honored if logs including IP addresses and timestamps are not supplied of suspected IVT-generated impressions for verification. These logs also enable us to ensure that we filter out future IVT visitations from these addresses if deemed valid. Harborside will supply a report back of any IVT traffic deemed valid along with supporting evidence.

Additional Terms and Conditions

The publisher is not liable for delays in delivery and/or nondelivery in the event of an Act of God, action by any governmental or quasigovernmental entity, fire, flood, insurrection, riot, explosion, embargo, strikes (whether legal or illegal), labor or material shortage, transportation interruption of any kind, work slow-down, or any condition beyond the control of the publisher affecting production or delivery in any manner.

Insertion Order and Copy Regulations: Insertion instructions shall be supplied for every advertisement and shall clearly state the following information: name of publication, name of advertiser, date to be inserted, size of advertisement, identification of advertisement (proof of ad to be furnished if possible), plus any special instruction such as bleed and color.

Cancellation of space order forfeits the right to position protection.

The publisher’s liability for any error will not exceed the charge for the advertisement in question.

The publisher assumes no liability if for any reason it becomes necessary to omit an advertisement.

When change of copy, covered by an uncancelled insertion order, is not received by the closing date, copy run in the previous issue will be inserted.

Requests for specified position at ROB rates are given consideration, but no guarantee is made unless the position premium has been agreed to in the contract.

The publisher reserves the right to hold advertiser and/or its advertising agency jointly and severally liable for such monies as are due and payable to the publisher.

In the event that an advertiser is owed a credit as a result of adjustment of frequency rates, the publisher will provide credit only on future advertisements.

Payment Terms: Net 30 days of invoice date. Pre-payment discounts are available, contact publisher for more details.

Payment for New Advertisers: All new advertisers are required to prepay until credit and/or reference checks are completed. Once approved, Harborside payment terms are net 30 days. Contact the Harborside Finance Team at accounting@hbside.com for more details.

Viewability: 70% Viewability is current industry standard. Ads taking more than 3 seconds to load will not qualify for viewability makegoods. If there is a 10% difference between third-party reporting, a conversation ensues between client and Harborside.

Cancellation Policies

Print Cancellations: Cancellations in advertising by the advertiser or its agency may not be made after the closing date for the publication unless otherwise agreed to by both parties in writing.

Premium Position, Cover Tip, and Outsert Cancellations: Must be prior to 60 days of the published closing date. After the published closing date, any premium position, cover tip, or outsert is non-cancelable, and full payment is due.

Please see page 5 for list of premium positions.

Digital Cancellations for e-TOC’s and Evening News:

Advertiser may cancel the I/O as follows:

Cost per Thousand (CPM) Placements:

  • CPM cancellations range 14–90 days, by offering/timing
  • With minimum 30–90 days prior written notice: no penalty
  • With less than 30–90 days prior written notice: Advertiser is responsible for any contracted media to be served within 30–90 days

Cost per Engagement (CPE) Placements:

  • With minimum 90 days prior written notice: no penalty
  • With less than 90 days prior written notice: Advertiser is responsible for any contracted media to be served within 90 days
  • Viewability requirements will not be honored on Cost per Engagement (CPE) Campaigns

For Flat-Fee or Fixed Placements (e-TOC’s and Evening News)

  • With minimum of 30 days prior written notice:
    no penalty
  • With less than 30 days prior written notice: Advertiser is responsible for any contracted media to be served within 30 days
  • IVT and Viewability Campaign requirements will not be honored on Flat-Fee (SOV) or Fixed Placements

For Website or CPM Placements

  • With minimum of 14 days prior written notice: no penalty
  • For a yearly buy, an advertiser can cancel twice with 14 days' notice. All ensuing cancellations will require 30 days prior notice to avoid penalty charge

Contact

Editor-in-Chief
James O. Armitage, MD, FASCO

President
Lori Pierce, MD, FASTRO, FASCO

President-Elect
Everett E. Vokes, MD, FASCO

Chief Executive Officer
Clifford A. Hudis, MD, FACP, FASCO


Chairman
John A. Gentile, Jr.
jgentile@hbside.com

President
Anthony Cutrone
acutrone@hbside.com

Executive Vice President
Conor Lynch
clynch@hbside.com

VP, Director of Advertising Sales
Leslie Dubin
631-935-7660
ldubin@hbside.com

VP, Senior Accounts Manager
Nick Vroom
917-538-0699
nvroom@hbside.com

National Accounts Representative
Shannon Meserve
631-935-7651
smeserve@hbside.com

Production Manager
Norman W. Virtue
631-935-7682
nvirtue@hbside.com

SVP, Director of Sales
David Horowitz
631-935-7652
dhorowitz@hbside.com

Advertising Sales Coordinator
Natalie King
631-935-7695
nking@hbside.com

Ad Operations Group
digitalads@hbside.com